Pinsent Masons advises Synova Capital on DBG (UK) Limited disposal

17 Apr 2013 | 02:08 pm | 1 min. read

International law firm Pinsent Masons has advised Synova Capital on its disposal of DBG (UK) Limited to global alternative asset manager The Carlyle Group and Palamon Capital Partners.

Operating for over 20 years, dbg is a specialist healthcare support services provider of training, compliance support, engineering services, materials and equipment. Using a membership-based model, dbg works alongside over 8,000 dental, GP and veterinary practices throughout the UK, and is headquartered in Winsford, Cheshire.

Philip Shapiro, Managing Partner at Synova commented “We are very pleased with the completion of our successful investment in dbg. Since we acquired dbg in 2010, the membership base has more than doubled and profits have trebled.  Carlyle and Palamon have a clear vision and ability to continue this growth.”

Eric Kump, Managing Director at Carlyle said “dbg is a well-established business delivering clear benefits to its members, customers and suppliers. Carlyle and Palamon have a strong track record in this sector, having acquired Integrated Dental Holdings (“IDH”) in 2011.”

KPMG Corporate Finance acted as lead advisor, with Synova being advised by Andrew Hodgson and Tim Spooner. Andrew, Corporate Finance Partner at KPMG Bristol said that "dbg is an outstanding business and Synova has done a great job in reading how the market was developing and focusing dbg’s strategy accordingly.  dbg’s recent and forecast growth made it a very attractive business and I fully expect it to go from strength to strength in partnership with its new owners."

The Pinsent Masons team advising Synova on the deal was led by Corporate Partner Peter Wood and Senior Associate Michael Walby.  Commenting on the deal, Michael said: "We are very pleased to have worked with Synova and the dbg management team on this important transaction and wish dbg well in the next exciting stage of its development.”

Latest press releases

Show me all press releases

Pinsent Masons appoints Sarah Derbyshire as General Counsel

Multinational law firm Pinsent Masons has appointed Sarah Derbyshire as General Counsel.

Orbital launches Scots Law workflows for Commercial Real Estate following pilot with Pinsent Masons

Orbital has built specific workflows for Scottish commercial real estate work, built around Scots Law and Scottish real estate practice 

Pinsent Masons advises on £230m plus Penta Real Estate and Staycity Group London aparthotel joint venture

Multinational law firm Pinsent Masons has advised Penta Real Estate on its investment into a landmark £230 million-plus joint venture with Staycity Group and advised the joint venture on the financing arrangements for the development, which will deliver a 350-room Wilde aparthotel in the heart of London's Farringdon district. 

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises SERT on transformational internalisation

Multinational law firm Pinsent Masons has advised Stoneweg Europe Stapled Trust (SERT) on its proposed aggregate c.€122 million acquisition of Stoneweg's pan-European investment management platform, a transformational transaction that will establish SERT as a fully integrated real estate owner, operator and investment manager with approximately €3.2 billion of assets under management.

Pinsent Masons advises FTI Consulting on sale of CX Lavender key client business to Omnicom Oceania

Multinational law firm Pinsent Masons has advised FTI Consulting, in its capacity as administrators of the CX Lavender group, on the sale of the company's key client-related business and associated workforce to Omnicom Oceania via its subsidiary, Clemenger BBDO Pty Ltd. The transaction completed in Q2 2026.

Pinsent Masons advises Horizon 3 Healthcare on investment in Xeltis

Multinational law firm Pinsent Masons has advised Horizon 3 Healthcare as lead investor in an additional €20.5 million funding round for Xeltis, a clinical-stage medtech company developing transformative implantable medical devices.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.